Syneron Candela’s PicoWay picosecond laser — previously indicated for tattoo removal — has won an expanded FDA indication for the treatment of pigmented lesions, and has received Health Canada clearance for both indications, the Israel-based devicemaker announced Monday.
A dual wavelength device, PicoWay uses a picosecond pulse, occurring at one trillionth of second, to create a high-energy, ultra-short photo-mechanical impact that breaks down tattoo ink or pigmentation.
The laser boasts the shortest picosecond pulse and highest peak power on the market, claims CEO Amit Meridor.
The product launched in the fourth quarter of 2014 in the U.S. and is expected to launch in the second quarter of 2015 in Canada.
Founded in 2000, Syneron Candela markets aesthetic devices in 86 countries. — Jason Scott